Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium-dependent phosphate transporter type IIb (NaPi-IIb/SLC34A2) is a critical epithelial membrane protein responsible for electrogenic cotransport of sodium ions with inorganic phosphate—primarily facilitating dietary phosphorus uptake from the intestine but also functioning in other organs such as lung. Its activity directly impacts whole-body phosphorus balance. Mutations can cause rare diseases like pulmonary alveolar microlithiasis; overexpression on certain tumors makes it an attractive target for antibody-drug conjugate therapies under development for cancers such as ovarian carcinoma. Downregulation or dysfunction may contribute to disordered mineral metabolism seen in chronic kidney disease patients.
Electrogenic cotransport of 3 Na+ : 1 HPO4(2−)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-dependent phosphate transporter type IIb (NaPi-IIb).